Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation.

about

Dermatological Complications After Solid Organ Transplantation.Prevention of chronic rejection after lung transplantation.

P2860

Q47572587-F671F52F-FC7A-47D7-8F20-C08B3AC96793 Q47662940-1658D2FA-CC2A-43C0-B04B-0F188230B4CF

P2860

Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation.

Item

http://www.wikidata.org/entity/Q40491238

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Voriconazole increases the ris ...... ma after lung transplantation.

@en

type

Item

label

Voriconazole increases the ris ...... ma after lung transplantation.

@en

prefLabel

Voriconazole increases the ris ...... ma after lung transplantation.

@en

P1476

Voriconazole increases the ris ...... ma after lung transplantation.

@en

P2093

Abbas Ardehali

http://www.w3.org/2001/XMLSchema#string

Alice Zhang

http://www.w3.org/2001/XMLSchema#string

Ariss DerHovanessian

http://www.w3.org/2001/XMLSchema#string

Bernie M Kubak

http://www.w3.org/2001/XMLSchema#string

David Elashoff

http://www.w3.org/2001/XMLSchema#string

David J Ross

http://www.w3.org/2001/XMLSchema#string

David M Sayah

http://www.w3.org/2001/XMLSchema#string

David T Barba

http://www.w3.org/2001/XMLSchema#string

Erin Duffy

http://www.w3.org/2001/XMLSchema#string

Jenny Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of invasive mold infections in lung transplant recipients

Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome

High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.

Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study

Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.

Is universal antifungal prophylaxis mandatory in lung transplant patients?

Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey.

Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.

Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.

Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.

P304

41-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRI.12865

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas A Kolaitis

P577

2016-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27678492

http://www.w3.org/2001/XMLSchema#string

P921

lung transplant

Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation.

about

P2860

P2860

Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921